Geoffrey D. Wool, MD, PhD

Publications

• Platelet factor 4 antibody persistence and long-term pathogenicity in vaccine-induced immune thrombotic thrombocytopenia.

  (Kanack A, Mauch E, Roberge G, Splinter N, Gundabolu K, Wool GD, George G, Abou-Ismail MY, Smock KJ, Green DL, Coker J, Kohlhagen MC, Murray DL, Padmanabhan A.) J Thromb Haemost. 2026 Jul;24(7):2514-2521 PMID: 41936925 PMCID: PMC13189683 04/06/2026

• Advances in Hemostasis Laboratory Testing.

  (Wool GD.) Clin Lab Med. 2026 Jun;46(2):xiii-xiv PMID: 42140692 05/16/2026

• Updates in Antiphospholipid Syndrome Laboratory Diagnosis.

  (Wool GD.) Clin Lab Med. 2026 Jun;46(2):295-311 PMID: 42140686 05/16/2026

• D-Dimer Reporting and Harmonization: Analysis of College of American Pathologists D-Dimer Proficiency Testing Program.

  (Salazar E, Smock KJ, Cazzolli T, Dlott JS, Lickteig N, Long TA, Mulvey JJ, Gil MR, Rollins-Raval M, Teruya J, Volod O, Walker CA, Wool GD, Zantek ND, Goodwin Iv AJ.) Semin Thromb Hemost. 2026 Mar 06 PMID: 41651008 02/07/2026

• Targeting BCMA in Plasmablastic Lymphoma With Teclistamab: A Case Study of Three Patients.

  (Cannova JM, DuVall AS, Kline J, Feinberg N, Wool GD, Riedell PA.) J Natl Compr Canc Netw. 2026 Feb 19;24(3):128-131 PMID: 41771248 PMCID: PMC13077976 03/03/2026

• Platelet Factor 4 Antibody Persistence and Long-term Pathogenicity in Vaccine-induced Immune Thrombotic Thrombocytopenia.

  (Kanack A, Mauch E, Roberge G, Splinter N, Gundabolu K, Wool GD, George G, Abou-Ismail MY, Smock KJ, Green DL, Coker J, Kohlhagen MC, Murray DL, Padmanabhan A.) medRxiv. 2025 Nov 27 PMID: 41358289 PMCID: PMC12676393 12/08/2025

• Pharmacogenomic Testing: Strategies and Technical Considerations for Clinical Laboratories.

  (Ji Y, Brunk L, Bove B, Danyal K, Langman LJ, Mot N, Mroz P, Natowicz M, Reddi H, Shirts B, Smock K, Wool GD, Zhang BM, Moyer AM.) Arch Pathol Lab Med. 2025 Nov 22;150(5):339-353 PMID: 41270809 11/22/2025

• Karyotypic clonal fraction predicts adverse outcome in TP53-mutated myeloid neoplasms: an International TP53 investigators Network (iTiN) study.

  (Pandiri M, Stengel A, Zhang J, Wang P, Shao H, Velmurugan S, Jacob A, Symes E, Kaur A, Rojek A, Sojitra P, Wiredja D, Zhou Q, Chang H, Patil E, Patel JL, Patel AB, Menon M, Ghosh S, Wool GD, Arber DA, Pan Z, Findley A, Badar T, Tariq H, Sallman D, Bell RC, Perry A, Haferlach C, Fitzpatrick C, Venkataraman G.) J Clin Pathol. 2025 Aug 18;78(9):629-635 PMID: 40571403 06/27/2025

• The Role of Therapeutic Plasma Exchange in Treating Hypertriglyceridemia-Associated Acute Pancreatitis: A Real-World Effectiveness Analysis Using the TriNetX Global Collaborative Network.

  (Amin N, Carll T, Chela H, Kamran A, Wool GD, Daglilar E.) J Clin Apher. 2025 Aug;40(4):e70053 PMID: 40873124 08/28/2025

• Assessment of Catheter-Directed Thrombolysis and Histotripsy Treatment for Deep Vein Thrombosis.

  (Zhao K, Saucedo E, Basterrechea KF, Yang S, Haworth KJ, Holland CK, Racadio JM, Maxwell AD, Cursio JF, Wool GD, Ostdiek AM, Ahmed OS, Paul JD, Patel MV, Bader KB.) J Vasc Interv Radiol. 2025 Jun;36(6):1051-1061.e5 PMID: 39890017 PMCID: PMC12103285 02/01/2025

• Ratios of calcium to citrate administration in blood transfusion for traumatic hemorrhage: A retrospective cohort study.

  (Alghanem H, Liu NC, Gupta A, Liao C, Wool GD, Rubin DS, Carll T.) Transfusion. 2024 Nov;64(11):2104-2113 PMID: 39351914 PMCID: PMC11573635 10/01/2024

• Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.

  (Streiff MB, Holmstrom B, Angelini D, Ashrani A, Buckner T, Diep R, Fertrin KY, Fogerty AE, Crestani NG, Gangaraju R, Rojas-Hernandez C, Goldhaber SZ, Ibrahim I, Kubal T, Leavitt AD, Lim M, Mann J, Mantha S, Morton C, Nester A, O'Brien A, Ortel TL, Pine A, Pishko A, Ranade M, Salmasi A, Schaefer J, Williams E, Wool G, Wun T, Montgomery S, Nguyen J, Freedman-Cass D, Sliker B.) J Natl Compr Canc Netw. 2024 Sep;22(7):483-506 PMID: 39236759 09/06/2024